Rebecca Assaraf, Editor

About the Author Rebecca Assaraf, Editor


Wedbush Shares Two Cents On Catabasis Pharmaceuticals (CATB) Following Clinical Results In DMD

Catabasis Pharmaceuticals (NASDAQ:CATB) investors endured a roller coaster ride in a just a few hours, …

Read more

Aurinia Pharmaceuticals, Inc. (AUPH) Scores Again With Voclosporin

Last week, on April 20, during the National Kidney Foundation 2017 Spring Clinical Meeting in …

Read more

Will Q1 Earnings Hold a Surprise for Amazon.com, Inc. (AMZN)? Top Analyst Answers

World’s top online retailer Amazon.com, Inc. (NASDAQ:AMZN) releases its first quarterly earnings report for the …

Read more

Amazon.com, Inc (AMZN) Q1 Beat Just Around The Corner?

World’s top online retailer Amazon.com, Inc. (NASDAQ:AMZN) is expected to release its first quarterly earnings …

Read more

Facebook Inc (FB) F8 Developer Conference Leaves Top Analysts Bullish On Shares

World’s largest social network Facebook Inc (NASDAQ:FB) gave its annual F8 Developer Conference in the …

Read more

FBR Capital Gets Bearish on Under Armour Inc (UAA) and Slices Price Target

The sportswear and footwear maker Under Armour Inc (NYSE:UAA) displays several disappointing elements as war …

Read more

Paratek Pharmaceuticals Inc (PTRK) Well on the Way to Broad Market Opportunity Following Successful Phase 3 for Omadacycline

Paratek Pharmaceuticals Inc (NASDAQ:PRTK) shares rose by nearly 31% after the microcap acne medicine maker …

Read more